{"entity":{"type":"insider","cik":"0001525354","url":"/insider/0001525354","json_url":"/insider/0001525354.json","name":"Shkreli Martin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":58,"n_filings":40,"first":"2012-12-28","last":"2016-08-29","span_basis":"filed_date"},"name_variants":[{"name":"Shkreli Martin","source":"filing","n_filings":40,"first_seen":"2012-12-28","last_seen":"2016-08-29"}],"transactions":[{"id":2777935,"accession":"0001104659-16-141736","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-141736","line_url":"/filing/0001104659-16-141736#line-2","is_derivative":false,"issuer_cik":"0001293310","issuer_name":"KALOBIOS PHARMACEUTICALS INC","issuer_ticker":"KBIO","issuer_name_source":null,"issuer_url":"/issuer/0001293310","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":309723.0,"shares_display":"309,723","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":960141.3,"total_display":"960,141.30","total_whole":"960,141","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-26","filed_date":"2016-08-29","scope":"insider"},{"id":2777927,"accession":"0001104659-16-141736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-141736","line_url":"/filing/0001104659-16-141736#line-1","is_derivative":false,"issuer_cik":"0001293310","issuer_name":"KALOBIOS PHARMACEUTICALS INC","issuer_ticker":"KBIO","issuer_name_source":null,"issuer_url":"/issuer/0001293310","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1913206.0,"shares_display":"1,913,206","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":5930938.6,"total_display":"5,930,938.60","total_whole":"5,930,939","shares_owned_after":309723.0,"shares_owned_after_display":"309,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-25","filed_date":"2016-08-29","scope":"insider"},{"id":8810165,"accession":"0001144204-15-067701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-067701","line_url":"/filing/0001144204-15-067701#line-1","is_derivative":false,"issuer_cik":"0001293310","issuer_name":"KALOBIOS PHARMACEUTICALS INC","issuer_ticker":"KBIO","issuer_name_source":null,"issuer_url":"/issuer/0001293310","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":38.15,"price_display":"38.15","price_state":"stated","total_value":190750.0,"total_display":"190,750.00","total_whole":"190,750","shares_owned_after":2075200.0,"shares_owned_after_display":"2,075,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-24","filed_date":"2015-11-24","scope":"insider"},{"id":8568601,"accession":"0001144204-15-067473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-067473","line_url":"/filing/0001144204-15-067473#line-1","is_derivative":false,"issuer_cik":"0001293310","issuer_name":"KALOBIOS PHARMACEUTICALS INC","issuer_ticker":"KBIO","issuer_name_source":null,"issuer_url":"/issuer/0001293310","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":18.88,"price_display":"18.88","price_state":"stated","total_value":94400.0,"total_display":"94,400.00","total_whole":"94,400","shares_owned_after":2070200.0,"shares_owned_after_display":"2,070,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-20","filed_date":"2015-11-23","scope":"insider"},{"id":8298850,"accession":"0001144204-15-066900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-066900","line_url":"/filing/0001144204-15-066900#line-1","is_derivative":false,"issuer_cik":"0001293310","issuer_name":"KALOBIOS PHARMACEUTICALS INC","issuer_ticker":"KBIO","issuer_name_source":null,"issuer_url":"/issuer/0001293310","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":440000.0,"shares_display":"440,000","price_per_share":2.02,"price_display":"2.02","price_state":"stated","total_value":888800.0,"total_display":"888,800.00","total_whole":"888,800","shares_owned_after":2065200.0,"shares_owned_after_display":"2,065,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-18","filed_date":"2015-11-19","scope":"insider"},{"id":8062310,"accession":"0001144204-15-066696","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-15-066696","line_url":"/filing/0001144204-15-066696","is_derivative":false,"issuer_cik":"0001293310","issuer_name":"KALOBIOS PHARMACEUTICALS INC","issuer_ticker":"KBIO","issuer_name_source":null,"issuer_url":"/issuer/0001293310","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":613677.0,"shares_display":"613,677","price_per_share":1.9357033260167809,"price_display":"1.94","price_state":"stated","total_value":1187896.61,"total_display":"1,187,896.61","total_whole":"1,187,897","shares_owned_after":1618200.0,"shares_owned_after_display":"1,618,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-17","filed_date":"2015-11-18","scope":"insider","n_lines":2},{"id":8062302,"accession":"0001144204-15-066696","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-066696","line_url":"/filing/0001144204-15-066696","is_derivative":false,"issuer_cik":"0001293310","issuer_name":"KALOBIOS PHARMACEUTICALS INC","issuer_ticker":"KBIO","issuer_name_source":null,"issuer_url":"/issuer/0001293310","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":597438.0,"shares_display":"597,438","price_per_share":0.7435043636327117,"price_display":"0.74","price_state":"stated","total_value":444197.76,"total_display":"444,197.76","total_whole":"444,198","shares_owned_after":914254.0,"shares_owned_after_display":"914,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-16","filed_date":"2015-11-18","scope":"insider","n_lines":2},{"id":6421454,"accession":"0001213900-14-008549","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001213900-14-008549","line_url":"/filing/0001213900-14-008549#line-6","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":252847.0,"shares_display":"252,847","price_per_share":8.41,"price_display":"8.41","price_state":"stated","total_value":2126443.27,"total_display":"2,126,443.27","total_whole":"2,126,443","shares_owned_after":1765168.0,"shares_owned_after_display":"1,765,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-21","filed_date":"2014-11-24","scope":"insider"},{"id":6421451,"accession":"0001213900-14-008549","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001213900-14-008549","line_url":"/filing/0001213900-14-008549#line-5","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":134354.0,"shares_display":"134,354","price_per_share":8.2319,"price_display":"8.23","price_state":"stated","total_value":1105988.6926,"total_display":"1,105,988.69","total_whole":"1,105,989","shares_owned_after":2018015.0,"shares_owned_after_display":"2,018,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-20","filed_date":"2014-11-24","scope":"insider"},{"id":6421448,"accession":"0001213900-14-008549","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001213900-14-008549","line_url":"/filing/0001213900-14-008549#line-4","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":329824.0,"shares_display":"329,824","price_per_share":8.5412,"price_display":"8.54","price_state":"stated","total_value":2817092.7488,"total_display":"2,817,092.75","total_whole":"2,817,093","shares_owned_after":2152369.0,"shares_owned_after_display":"2,152,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-19","filed_date":"2014-11-24","scope":"insider"},{"id":6421440,"accession":"0001213900-14-008549","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-14-008549","line_url":"/filing/0001213900-14-008549#line-3","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":254975.0,"shares_display":"254,975","price_per_share":9.1911,"price_display":"9.19","price_state":"stated","total_value":2343500.7225,"total_display":"2,343,500.72","total_whole":"2,343,501","shares_owned_after":2482193.0,"shares_owned_after_display":"2,482,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-24","scope":"insider"},{"id":6421437,"accession":"0001213900-14-008549","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-14-008549","line_url":"/filing/0001213900-14-008549#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":9.411,"price_display":"9.41","price_state":"stated","total_value":941100.0,"total_display":"941,100.00","total_whole":"941,100","shares_owned_after":2737168.0,"shares_owned_after_display":"2,737,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-17","filed_date":"2014-11-24","scope":"insider"},{"id":6421433,"accession":"0001213900-14-008549","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-14-008549","line_url":"/filing/0001213900-14-008549#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":10.2279,"price_display":"10.23","price_state":"stated","total_value":1022790.0,"total_display":"1,022,790.00","total_whole":"1,022,790","shares_owned_after":2837168.0,"shares_owned_after_display":"2,837,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-14","filed_date":"2014-11-24","scope":"insider"},{"id":6787411,"accession":"0001193805-14-001950","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-14-001950","line_url":"/filing/0001193805-14-001950#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","total_whole":"3,000","shares_owned_after":2662168.0,"shares_owned_after_display":"2,662,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-09","scope":"insider"},{"id":6787408,"accession":"0001193805-14-001950","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-001950","line_url":"/filing/0001193805-14-001950#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":8.1066,"price_display":"8.11","price_state":"stated","total_value":202665.0,"total_display":"202,665.00","total_whole":"202,665","shares_owned_after":2962168.0,"shares_owned_after_display":"2,962,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-09","scope":"insider"},{"id":6754035,"accession":"0001193805-14-001927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-001927","line_url":"/filing/0001193805-14-001927#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":9.42,"price_display":"9.42","price_state":"stated","total_value":37680.0,"total_display":"37,680.00","total_whole":"37,680","shares_owned_after":2937168.0,"shares_owned_after_display":"2,937,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-30","filed_date":"2014-10-02","scope":"insider"},{"id":6554318,"accession":"0001193805-14-001860","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-14-001860","line_url":"/filing/0001193805-14-001860#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":10.8202,"price_display":"10.82","price_state":"stated","total_value":378707.0,"total_display":"378,707.00","total_whole":"378,707","shares_owned_after":2933168.0,"shares_owned_after_display":"2,933,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-22","filed_date":"2014-09-23","scope":"insider"},{"id":6554317,"accession":"0001193805-14-001860","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-001860","line_url":"/filing/0001193805-14-001860#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18000.0,"shares_display":"18,000","price_per_share":11.7797,"price_display":"11.78","price_state":"stated","total_value":212034.6,"total_display":"212,034.60","total_whole":"212,035","shares_owned_after":2898168.0,"shares_owned_after_display":"2,898,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-19","filed_date":"2014-09-23","scope":"insider"},{"id":6185889,"accession":"0001193805-14-001834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-001834","line_url":"/filing/0001193805-14-001834#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":11.4567,"price_display":"11.46","price_state":"stated","total_value":68740.2,"total_display":"68,740.20","total_whole":"68,740","shares_owned_after":2880168.0,"shares_owned_after_display":"2,880,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-17","filed_date":"2014-09-18","scope":"insider"},{"id":6185884,"accession":"0001193805-14-001829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-001829","line_url":"/filing/0001193805-14-001829#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":10.692,"price_display":"10.69","price_state":"stated","total_value":80190.0,"total_display":"80,190.00","total_whole":"80,190","shares_owned_after":2874168.0,"shares_owned_after_display":"2,874,168","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-16","filed_date":"2014-09-16","scope":"insider"},{"id":6674651,"accession":"0001193805-14-001168","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-14-001168","line_url":"/filing/0001193805-14-001168#line-3","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":292400.0,"shares_display":"292,400","price_per_share":15.14,"price_display":"15.14","price_state":"stated","total_value":4426936.0,"total_display":"4,426,936.00","total_whole":"4,426,936","shares_owned_after":2866668.0,"shares_owned_after_display":"2,866,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-30","filed_date":"2014-06-03","scope":"insider"},{"id":6941785,"accession":"0001193805-14-000711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000711","line_url":"/filing/0001193805-14-000711#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":19.6431,"price_display":"19.64","price_state":"stated","total_value":157144.8,"total_display":"157,144.80","total_whole":"157,145","shares_owned_after":2982680.0,"shares_owned_after_display":"2,982,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-04","filed_date":"2014-04-07","scope":"insider"},{"id":6993646,"accession":"0001193805-14-000694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000694","line_url":"/filing/0001193805-14-000694#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22500.0,"shares_display":"22,500","price_per_share":22.5974,"price_display":"22.60","price_state":"stated","total_value":508441.5,"total_display":"508,441.50","total_whole":"508,442","shares_owned_after":2974680.0,"shares_owned_after_display":"2,974,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-03","filed_date":"2014-04-04","scope":"insider"},{"id":7067537,"accession":"0001193805-14-000684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000684","line_url":"/filing/0001193805-14-000684#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10800.0,"shares_display":"10,800","price_per_share":22.2792,"price_display":"22.28","price_state":"stated","total_value":240615.36,"total_display":"240,615.36","total_whole":"240,615","shares_owned_after":2952180.0,"shares_owned_after_display":"2,952,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-02","filed_date":"2014-04-03","scope":"insider"},{"id":6966325,"accession":"0001193805-14-000635","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000635","line_url":"/filing/0001193805-14-000635#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":17.6099,"price_display":"17.61","price_state":"stated","total_value":70439.6,"total_display":"70,439.60","total_whole":"70,440","shares_owned_after":2941380.0,"shares_owned_after_display":"2,941,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-24","filed_date":"2014-03-27","scope":"insider"},{"id":7010832,"accession":"0001193805-14-000541","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000541","line_url":"/filing/0001193805-14-000541#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":17.97,"price_display":"17.97","price_state":"stated","total_value":89850.0,"total_display":"89,850.00","total_whole":"89,850","shares_owned_after":2937380.0,"shares_owned_after_display":"2,937,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-20","filed_date":"2014-03-21","scope":"insider"},{"id":6787402,"accession":"0001193805-14-000482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000482","line_url":"/filing/0001193805-14-000482#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":18.4448,"price_display":"18.44","price_state":"stated","total_value":64556.8,"total_display":"64,556.80","total_whole":"64,557","shares_owned_after":2932380.0,"shares_owned_after_display":"2,932,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-19","filed_date":"2014-03-20","scope":"insider"},{"id":6221565,"accession":"0001193805-14-000450","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000450","line_url":"/filing/0001193805-14-000450#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":17.3612,"price_display":"17.36","price_state":"stated","total_value":69444.8,"total_display":"69,444.80","total_whole":"69,445","shares_owned_after":2928880.0,"shares_owned_after_display":"2,928,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-14","filed_date":"2014-03-17","scope":"insider"},{"id":6871195,"accession":"0001193805-14-000431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000431","line_url":"/filing/0001193805-14-000431#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25900.0,"shares_display":"25,900","price_per_share":19.4744,"price_display":"19.47","price_state":"stated","total_value":504386.96,"total_display":"504,386.96","total_whole":"504,387","shares_owned_after":2924880.0,"shares_owned_after_display":"2,924,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-11","filed_date":"2014-03-12","scope":"insider"},{"id":7051859,"accession":"0001193805-14-000423","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000423","line_url":"/filing/0001193805-14-000423#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10700.0,"shares_display":"10,700","price_per_share":19.3188,"price_display":"19.32","price_state":"stated","total_value":206711.16,"total_display":"206,711.16","total_whole":"206,711","shares_owned_after":2898980.0,"shares_owned_after_display":"2,898,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-10","filed_date":"2014-03-11","scope":"insider"},{"id":6343704,"accession":"0001193805-14-000416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-14-000416","line_url":"/filing/0001193805-14-000416#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2498.0,"shares_display":"2,498","price_per_share":18.2619,"price_display":"18.26","price_state":"stated","total_value":45618.2262,"total_display":"45,618.23","total_whole":"45,618","shares_owned_after":2888280.0,"shares_owned_after_display":"2,888,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-03-10","scope":"insider"},{"id":6343699,"accession":"0001193805-14-000416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000416","line_url":"/filing/0001193805-14-000416#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1560.0,"shares_display":"1,560","price_per_share":18.9282,"price_display":"18.93","price_state":"stated","total_value":29527.992,"total_display":"29,527.99","total_whole":"29,528","shares_owned_after":2885782.0,"shares_owned_after_display":"2,885,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-10","scope":"insider"},{"id":6941781,"accession":"0001193805-14-000398","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000398","line_url":"/filing/0001193805-14-000398#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":18.4765,"price_display":"18.48","price_state":"stated","total_value":73906.0,"total_display":"73,906.00","total_whole":"73,906","shares_owned_after":2884222.0,"shares_owned_after_display":"2,884,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-05","filed_date":"2014-03-06","scope":"insider"},{"id":6586083,"accession":"0001193805-14-000387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-14-000387","line_url":"/filing/0001193805-14-000387#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43000.0,"shares_display":"43,000","price_per_share":18.6669,"price_display":"18.67","price_state":"stated","total_value":802676.7,"total_display":"802,676.70","total_whole":"802,677","shares_owned_after":2880222.0,"shares_owned_after_display":"2,880,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-28","filed_date":"2014-03-03","scope":"insider"},{"id":6586080,"accession":"0001193805-14-000387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000387","line_url":"/filing/0001193805-14-000387#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":17.2,"price_display":"17.20","price_state":"stated","total_value":1720.0,"total_display":"1,720.00","total_whole":"1,720","shares_owned_after":2837222.0,"shares_owned_after_display":"2,837,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-21","filed_date":"2014-03-03","scope":"insider"},{"id":6288917,"accession":"0001193805-14-000368","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000368","line_url":"/filing/0001193805-14-000368#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1600.0,"shares_display":"1,600","price_per_share":17.5637,"price_display":"17.56","price_state":"stated","total_value":28101.92,"total_display":"28,101.92","total_whole":"28,102","shares_owned_after":2837122.0,"shares_owned_after_display":"2,837,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-21","filed_date":"2014-02-25","scope":"insider"},{"id":6966320,"accession":"0001193805-14-000342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000342","line_url":"/filing/0001193805-14-000342#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":14.6018,"price_display":"14.60","price_state":"stated","total_value":51106.3,"total_display":"51,106.30","total_whole":"51,106","shares_owned_after":2835522.0,"shares_owned_after_display":"2,835,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-14","filed_date":"2014-02-19","scope":"insider"},{"id":6463838,"accession":"0001193805-14-000180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000180","line_url":"/filing/0001193805-14-000180#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":9.916,"price_display":"9.92","price_state":"stated","total_value":19832.0,"total_display":"19,832.00","total_whole":"19,832","shares_owned_after":2832022.0,"shares_owned_after_display":"2,832,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-06","filed_date":"2014-02-07","scope":"insider"},{"id":6993639,"accession":"0001193805-14-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000060","line_url":"/filing/0001193805-14-000060#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":10.8368,"price_display":"10.84","price_state":"stated","total_value":86694.4,"total_display":"86,694.40","total_whole":"86,694","shares_owned_after":2830022.0,"shares_owned_after_display":"2,830,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-14","filed_date":"2014-01-15","scope":"insider"},{"id":6463811,"accession":"0001193805-14-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000002","line_url":"/filing/0001193805-14-000002#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":1050000.0,"total_display":"1,050,000.00","total_whole":"1,050,000","shares_owned_after":2816246.0,"shares_owned_after_display":"2,816,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-31","filed_date":"2014-01-02","scope":"insider"},{"id":5034642,"accession":"0001193805-13-002242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-13-002242","line_url":"/filing/0001193805-13-002242#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":8.11,"price_display":"8.11","price_state":"stated","total_value":811.0,"total_display":"811.00","total_whole":"811","shares_owned_after":2666246.0,"shares_owned_after_display":"2,666,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-09","filed_date":"2013-12-10","scope":"insider"},{"id":5034635,"accession":"0001193805-13-002242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-13-002242","line_url":"/filing/0001193805-13-002242#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":8.3,"price_display":"8.30","price_state":"stated","total_value":830.0,"total_display":"830.00","total_whole":"830","shares_owned_after":2666146.0,"shares_owned_after_display":"2,666,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-06","filed_date":"2013-12-10","scope":"insider"},{"id":4491688,"accession":"0001193805-13-002191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-13-002191","line_url":"/filing/0001193805-13-002191#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150.0,"shares_display":"150","price_per_share":6.8066,"price_display":"6.81","price_state":"stated","total_value":1020.99,"total_display":"1,020.99","total_whole":"1,021","shares_owned_after":2666046.0,"shares_owned_after_display":"2,666,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-26","filed_date":"2013-12-02","scope":"insider"},{"id":4491679,"accession":"0001193805-13-002191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-13-002191","line_url":"/filing/0001193805-13-002191#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":6.06,"price_display":"6.06","price_state":"stated","total_value":1818.0,"total_display":"1,818.00","total_whole":"1,818","shares_owned_after":2665896.0,"shares_owned_after_display":"2,665,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-22","filed_date":"2013-12-02","scope":"insider"},{"id":9256079,"accession":"0001193805-14-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-000059","line_url":"/filing/0001193805-14-000059#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5556.0,"shares_display":"5,556","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":25002.0,"total_display":"25,002.00","total_whole":"25,002","shares_owned_after":2665596.0,"shares_owned_after_display":"2,665,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-12","filed_date":"2014-01-14","scope":"insider"},{"id":4776887,"accession":"0001193805-13-001614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-13-001614","line_url":"/filing/0001193805-13-001614#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11112.0,"shares_display":"11,112","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":50004.0,"total_display":"50,004.00","total_whole":"50,004","shares_owned_after":2671152.0,"shares_owned_after_display":"2,671,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-12","filed_date":"2013-09-16","scope":"insider"},{"id":5449677,"accession":"0001193805-13-001517","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-13-001517","line_url":"/filing/0001193805-13-001517#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":6.02,"price_display":"6.02","price_state":"stated","total_value":6622.0,"total_display":"6,622.00","total_whole":"6,622","shares_owned_after":2660040.0,"shares_owned_after_display":"2,660,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-22","filed_date":"2013-08-23","scope":"insider"},{"id":5449674,"accession":"0001193805-13-001517","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-13-001517","line_url":"/filing/0001193805-13-001517#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001525354","owner_name":"Shkreli Martin","owner_display_name":"Shkreli Martin","owner_url":"/insider/0001525354","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2800.0,"shares_display":"2,800","price_per_share":6.08,"price_display":"6.08","price_state":"stated","total_value":17024.0,"total_display":"17,024.00","total_whole":"17,024","shares_owned_after":2658940.0,"shares_owned_after_display":"2,658,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-21","filed_date":"2013-08-23","scope":"insider"}],"collapsed":true,"next_cursor":"2013-08-21|5449674","ledger_fault":false,"count":{"value":58,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":48,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":58},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001293310","name":"KALOBIOS PHARMACEUTICALS INC","url":"/issuer/0001293310","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":5,"first_seen":"2015-11-18","last_seen":"2016-08-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001438533","name":"Retrophin, Inc.","url":"/issuer/0001438533","role":"Director, Officer (Chief Executive Officer), Ten percent owner, Other","n_filings":35,"first_seen":"2012-12-28","last_seen":"2014-11-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001525354","retrieved_at":"2026-08-27T07:21:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}